http://linkedlifedata.com/r... | rdf:type | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | Smith, C.K. | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | Moore, M.H. | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | Van Meervelt, L. | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | Turkenburg, J.P. | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | Schuerman, G.S. | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | Dettmar, A.N. | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 245D | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 5'-D(*TP*GP*AP*TP*CP*A)-3', NOGALAMYCIN, 150K, SHELXL-93 REFINEMENT | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | DNA-DRUG REFINEMENT: A COMPARISON OF THE PROGRAMS NUCLSQ, PROLSQ, SHELXL93 AND X-PLOR, USING THE LOW TEMPERATURE D(TGATCA)-NOGALAMYCIN STRUCTURE | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |